These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 300747)

  • 1. Characteristics of the immature cells involved in T cell-mediated enhancement of syngeneic tumor growth.
    Small M
    J Immunol; 1977 May; 118(5):1517-23. PubMed ID: 300747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing reactivities of subpopulations of T lymphocytes toward syngeneic tumor cells: separation of early thymocytes.
    Small M
    J Immunol; 1978 Sep; 121(3):1167-72. PubMed ID: 308521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
    Shanker A; Singh SM
    Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
    Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
    Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of immature cells from the thymus during solid tumor growth: identification by assay of TdT activity.
    Small M; Lasser-Weiss M; Daniel V
    J Immunol; 1979 Jul; 123(1):259-62. PubMed ID: 312875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ; Carnaud C; Trainin N; Feldman M; Cohen IR
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract]   [Full Text] [Related]  

  • 8. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y; Paul RD; Wang Y; Lopez DM
    J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive phenomena in experimental tumor systems (author's transl)].
    Reme TX
    Pathol Biol (Paris); 1977 Dec; 25(10):735-40. PubMed ID: 349487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell differentiation within thymic nurse cells.
    de Waal Malefijt R; Leene W; Roholl PJ; Wormmeester J; Hoeben KA
    Lab Invest; 1986 Jul; 55(1):25-34. PubMed ID: 3088330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal thymic atrophy after exposure to T-2 toxin: selectivity for lymphoid progenitor cells.
    Holladay SD; Blaylock BL; Comment CE; Heindel JJ; Luster MI
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):8-14. PubMed ID: 8337703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host endocrine responses during tumor growth.
    Besedovsky H; del Rey A; Normann SJ
    Prog Clin Biol Res; 1989; 288():203-13. PubMed ID: 2654951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional modifications of thymocytes during tumor growth.
    Lombardi D; Naso G; Ottavio L; Lenti L; Mardente S; Pontieri GM
    Thymus; 1992 Feb; 19(1):13-33. PubMed ID: 1566282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.